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ABSTRACT 
Hyaluronic  acid  (HA)  is  a  hydrated  gel  and  comprises  repeating  units  of 
glucuronic acid and N-acetylglucosamine. Production and recovery of HA has 
gained  great  importance  due  to  its  vast  clinical  applications.  In  pursuit  of 
obtaining highly pure HA, we have developed a fed-batch fermentation process 
using  Streptococcus  zooepidemicus  in  a  25  L  bioreactor  that  resulted  in  a 
maximum yield of 2.3 g/L HA. In addition, we have devised an efficient method 
for separation and recovery of hyaluronic acid from a highly viscous broth by 
treating with trichloroacetic acid (0.1%) and charcoal (1-2%), passing through 
filtration  (0.45  μm)  and  ultrafiltration  that  resulted  in  recovery  of  72.2%  of 
clinical  grade  HA  with  molecular  weight  of  2.5×10
6  Da.  We  have  also 
characterized our purified HA using FTIR and NMR spectroscopy. These studies 
revealed the similarity in both the FTIR spectrum as well as NMR spectrum of 
both reference standard and purified HA from S. zooepidemicus indicating that 
the reported process is more efficient in terms of better yield and high quality 
(99.2%). 
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Introduction 
Hyaluronic acid (HA) is a carbohydrate, more specifically 
a  mucopolysaccharide  occurring  naturally  throughout  the 
human body. Hyaluronan is a polymer of disaccharides. HA 
is comprised of linear, unbranching, polyanionic disaccharide 
units  consisting  of  glucuronic  acid  (GlcUA)  and  N-
acetylglucosamine  (GlcNAc)  linked  alternately  by  (β-1,3) 
and  (β-1,4)  glycosidic  bonds.  HA  has  been  conventionally 
extracted  from  rooster  combs  and  bovine  vitreous  humor. 
However, it is difficult to isolate high molecular weight HA 
at  industrially  feasible  rate  from  these  sources,  because  it 
forms complex with proteoglycans present in animal tissue. It 
is presently impractical to control the molecular weight of the 
biopolymer  while  it  is  synthesized  in  animal  tissue. 
Moreover, the use of animal-derived biochemicals for human 
therapeutics  has  raised  ethical  issues,  and  is  met  with 
growing  resistance.  To  overcome  these  disadvantages,  the 
recent trend involves the usage of Lancefield’s group A and 
group  C  Streptococci,  which  naturally  produce  a  mucoid 
capsule of HA. Streptococci are Gram-positive, nutritionally 
fastidious,  facultative  anaerobes,  nonmotile,  non-spore 
forming, catalase-negative cocci that occur in pairs or chains. 
Several studies have also reported on production of HA from 
Streptococcus zooepidemicus (Johns et al., 1994; Armstrong 
&  Johns,  1997;  Rangasamy  &  Jain  2008;  Jagadeeswara 
Reddy et al., 2011). 
The most significant clinical applications of HA are in the 
area  of  ophthalmology,  orthopedics,  and  wound  healing. 
Emerging uses include drug delivery, coatings, implants and 
therapeutics  related  application.  Sodium  hyaluronate 
injection is a viscoelastic, sterile solution of highly purified, 
high  molecular  weight  hyaluronan  in  phosphate-buffered 
saline. Therefore, majority of the research has focused mainly 
on  obtaining  a  highly  pure  HA  suitable  for  clinical 
applications  (Swann  &  Kuo,  1991).  Several  separation 
techniques  such  as  protease  digestion,  HA  ion-pair 
precipitation  (with  e.g.,  acetyl-pyridinium  chloride), 
membrane  ultrafiltration,  HA  non-solvent  precipitation  and 
lyophilization (Mendichi & Soltes, 2002; Soltes & Mendichi, ISSN: 1314-6246               Jagadeeswara Reddy & Karunakaran  J. BioSci. Biotech. 2013, 2(3): 173-179. 
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2003)  have  been  used  to  obtain  a  pure  compound.  Still  an 
economical and a simple method is needed for high grade and 
pure HA production for medical applications. 
Earlier we have reported on optimization of fermentation 
conditions for an enhanced HA production (1.89 g/L) by S. 
zooepidemicus mutant strain 3523-7 (Jagadeeswara Reddy et 
al., 2011). This study further describes on improving the HA 
production in a fed-batch fermentation process and a simple 
method of purification for high quality high molecular weight 
HA and its characterization. 
Materials and Methods 
Bacteria and media  
Streptococcus  equi  subspecies  zooepidemicus  mutant 
strain  3523-7  derived  from  MTCC  3523  (Jagadeeswara 
Reddy et al., 2011) was used in this study. Both strains were 
maintained  as  freeze-dried  cultures  and  stored  at  4ºC. 
Bacteria were sub cultured and grown by using one percent 
inoculums  in  Todd  Hewitt  broth  (Difco)  or  a  chemically 
defined  medium  (CDM)  containing  optimal  carbon  and 
nitrogen sources (Jagadeeswara Reddy et al., 2011).  
Hyaluronic acid fermentation using S. zooepidemicus 3523-7 
Fed batch culture experiments  were performed in 25  L 
bioreactor (Scigenics, India) with a working volume of 12 L 
chemically-defined  medium  (CDM).  The  bioreactor 
containing CDM was autoclaved at 121°C 15 lb/in
2 for 20 
min  and  allowed  to  cool  at  room  temperature.  Overnight 
CDM-grown  S.zooepidemicus  3523-7  was  used  as  an 
inoculum (1%). Agitation was provided by three four-bladed 
turbines, the pH of culture media was maintained as 7.2  0.2 
by  automatic  addition  of  5N-sodium  hydroxide  and 
temperature at 36ºC with automated regulation. The impeller 
speed (200-400 rpm) and aeration (0.4 to 0.5 vvm) in fed 
batch cultures of the bioreactor were optimized for defined 
culture  conditions.  As  for  the  established  conditions  initial 
glucose concentration maintained by adding 20 g/L glucose 
at  a  flow  rate  of  1  ml/min  from  the  stock  (220  g/L). 
Fermentation was allowed to continue in a batch mode until 
the sugar level reaches 0.1% (nearly 8-10 hours) and if the 
concentration of the sugar is less than 0.1%, the dilution rate 
of glucose was increased. Dilution rate was calculated using 
the formula: D=F/V. Dilution rate of glucose (from 13-14
th 
hour of the batch) was F = 60 ml/hr and D = 0.005 hr
-1. It was 
assured that the concentration of sugar in the batch should not 
exceed  0.1-0.2%  with  the  dilution  rate.  Nearly  at  13-14
th 
hour, dilution rate of glucose was increased to 2 ml/min to 
maintain residual sugar and then subsequently in fed-batch 
mode  with the feeding of glucose at the rate of 1 ml/min. 
Cells were harvested after heat killing the bacteria at the end 
of 20 hrs of fermentation when the final OD530 was at 4.7. 
The growth of the culture was determined by measuring 
optical density (OD) at A530 nm (Armstrong & Johns, 1997) 
with UV-Visible Spectrophotometer (Labomed Inc, USA) by 
using the medium without inoculation as reference blank. The 
culture samples were diluted with distilled water to give less 
than 1 OD at A530 nm.  
Isolation and purification of hyaluronic acid 
HA produced by S. zooepidemicus in fermentation broth 
was purified as described in literature (Brown et al., 1994; 
Han  et  al.,  2004;  Carlino  &  Magnette,  2002)  and  some 
modifications in its purification steps were made to improve 
the  recovery  and  purity  of  HA.  Crude  HA  present  in 
fermentation broth  was estimated by the carbazole  method 
(Bitter & Muir, 1962).  
The fermentation broth (Van  de Rijn  & Kessler, 1980) 
containing  >2.0  g  HA/L  was  precipitated  with  isopropyl 
alcohol  (1:3  v/v).  The  precipitated  HA  was  redissolved  in 
0.15 M sodium chloride solution so as to reduce the viscosity 
and concentration of HA (preferably up to 0.01 g HA/L). The 
nucleic acids and bacteria derived proteins present in crude 
samples were removed by lowering the pH of the broth from 
6  to  2  by  addition  of  trichloroacetic  acid  (0.1%)  and 
subsequent  charcoal  treatment  (1-2%)  for  1  h  followed  by 
centrifugation at 7000 rpm for 30 min at 4ºC.  
After  removal  of  cells  and  charcoal,  HA  solution  was 
passed  through  0.45  μm  filters  (293  mm  cassette  holder, 
Millipore,  USA).  The  filtered  HA  solution  was  fivefold 
diluted and further purified by ultrafiltration in diafiltration 
mode  (Millipore,  USA)  using  a  300  kDa  cut  off  cassette 
(Sartorius). Finally, the retentate containing HA sample was 
concentrated  to  original  volume  (one  liter  and  precipitated 
with  isopropyl  alcohol  (1:3  v/v).  This  step  of  isopropyl 
alcohol will remove any residuals of endotoxins left at the 
filtration  stage.  White  fibrous  aggregates  of  pure  sodium 
hyaluronate  were  precipitated  and  vacuum  dried  (Biotron, 
Korea). Endotoxin levels were measured using LAL reagent 
(Charles  River  Laboratories,  SC,  USA)  according  to  the 
manufacturer’s instruction. 
Molecular  weight  (MW)  of  HA  was  determined  by 
measuring intrinsic  viscosity  [η]  using  Cannon-Ubbelhodes 
Viscometer  (Cannon  Instrument  Co,  USA)  followed  by ISSN: 1314-6246               Jagadeeswara Reddy & Karunakaran  J. BioSci. Biotech. 2013, 2(3): 173-179. 
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substituting the intrinsic viscosity in Mark Houwink Equation 
(Martin, 1953; Laurent et al., 1960). The intrinsic viscosity 
[η] was assessed by British Pharmacopoeia method (2003). 
Characterization of hyaluronic acid by FTIR  
Characterization  of  HA  was  performed  by  FTIR 
Spectrophotometer  (Jasco,  Japan)  as  described  in  British 
Pharmacopoeia  (2003).  HA  obtained  by  extraction  and 
purification from the fed batch cultures of S. zooepidemicus 
was  compared  with  a  standard  sample  of  HA  (Sigma 
chemicals, USA).  
Dried  potassium  bromide  was  taken  into  mortar  and 
grinded with a pestle. 2 mg of standard HA (as a reference 
substance)  was then added and grounded to  get a  uniform 
mixture. The sample was evenly spread on the pelletier, and 
the pelletizing bit kept over it with the smooth surface facing 
towards the sample. The pelletier (Kimaya Engineers, India) 
was fixed and tightened by the screw head. Pressure was then 
applied slowly by using the lever to 10 tons (not exceeding 
10 tons). The pelletizer was depressurized after one minute 
with the help of the knob. The pellet was carefully collected 
from  the  pelletizer  and  placed  in  the  sample  holder  for 
measurement  in  the  FTIR  spectrophotometer.  In  a  similar 
manner, HA sample obtained from S. zooepidemicus was also 
prepared for FTIR spectrophotometer. The HA sample to be 
examined and the reference standard were both prepared by 
the  same  procedure  and  the  spectra  recorded  was  between 
4000-400  cm
-1  (2.5-25  μm)  under  the  same  operational 
conditions  against  air  as  blank.  All  organic  molecules  can 
absorb  FTIR  radiation  between  4000  cm
-1  and  400  cm
-1,
 
which  corresponds  to  absorption  of  energy  between  11 
kcal/M  and  1  kcal/M.  This  amount  of  energy  initiates 
transitions  between  vibrational  states  of  bonds  contained 
within  the  molecule.  The  transmission  minima  (absorption 
maxima)  in  the  spectrum  obtained  with  HA  sample  to  be 
examined  corresponds  to  the  position  and  relative  size  to 
those in the spectrum obtained with the reference substance. 
Characterization of hyaluronic acid by NMR spectroscopic 
analysis 
For determining the chemical structure of hyaluronic acid, 
analysis  of  the  C
13  nucleus  present  in  the  compound 
(hyaluronic acid) was studied by Nuclear magnetic resonance 
(NMR) spectroscopy (Bruker, Germany) as described below.  
Ten  milligrams  of  HA  sample  obtained  from  S. 
zooepidemicus was taken into a clean, dry 5 mm NMR tube 
(Wilmad glass). The compound was dissolved in 500 μl of 
D2O inside the NMR tube. Similarly the standard reference 
(10  mg  of  HA  in  500  μl  of  D2O)  was  prepared  for  the 
analysis. 
The isotropic solution for both the test HA and reference 
standard  has  been  prepared  in  D2O.  All  experiments  were 
performed  using  the  BRUKER  AMX  53  400  NMR 
spectrometer operated at 9.7 Tesla using 5 mm QNP probe. 
Standard Zgdc pulse program has been used to acquire the 
C
13 NMR spectra with Waltz-16 decoupling. The temperature 
was  maintained  at  300  K  using  standard  BRUKER  BVT 
temperature unit and the sample was not spun during the time 
of experiment. The spectra were recorded and the obtained 
spectrum  for  the  sample  was  compared  with  reference 
standard spectrum. 
Statistical analysis  
Data were expressed as mean ±SD obtained from at least 
three independent experiments. Statistical significance of the 
obtained results was verified by Student’s t-test and one way 
ANOVA  using  a  commercial  package  (Sigma  Plot  5.05). 
p<0.05  in  comparisons  to  controls  was  considered  as 
significant. 
Results and Discussion 
Hyaluronic acid production by S. zooepidemicus 3523-7 
S.  zooepidemicus  strain  3523-7  has  been  shown  to 
produce  ten  times  more  HA  compared  to  its  parent  strain 
(Jagadeeswara  Reddy  et  al,  2011).  We  have  employed  the 
same strain in the study in order to get better yields. During 
fed-batch  fermentation  growth,  HA  production  and  total 
sugar concentration were continuously monitored (Figure 1). 
At the end of 18 hrs, both the final OD530 of the culture (4.7) 
and HA production (2.34 g/L) reached the maximum. On the 
contrary, total sugar concentration started to decrease during 
the growth and HA production till the end of fermentation. 
Thus, the fermentation process has resulted in higher yield of 
HA compared to our previous study (Jagadeeswara Reddy et 
al, 2011). 
Isolation and purification of hyaluronic acid produced by S. 
zooepidemicus 3523-7 
Isolation and downstream purification process are crucial 
for  efficient  recovery  of  HA  from  the  fermentation  broth. 
Several  purification  procedures  have  been  employed 
previously for isolation and purification of HA (Brown et al., 
1994; Han et al., 2004). 
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Figure 1. Hyaluronic acid production by fed-batch fermentation by S. zooepidemicus strain 3523-7. A) Change in growth of S. 
zooepidemicus is shown by -♦- as a function of absorbance at OD530  and B) The change in hyaluronic acid production is shown as (-
●-) along with total sugar in CDM indicated by (-■-) are shown in line graph.  
 
The  release  of  HA  from  the  complexes  with  other 
polysaccharides  and  proteins  is  usually  achieved  by  using 
enzymes,  organic  solvents  and  detergents  (lauryl  sulfate, 
hexadecyltrimethyl  ammonium  bromide  etc.,)  and  anion 
exchange  resins  (Han  et  al.,  2004).  However  the  major 
disadvantage  associated  with  these  processes  are  higher 
production  cost  and  it  becomes  difficult  to  completely 
remove  exothermic  material,  proteins,  nucleic  acids,  etc., 
hence they are not preferred for scale up processes. In the 
present study, a novel, cost-effective purification process for 
highly pure HA has been developed. 
The  optimized  purification  process  (Table  1)  in  the 
present  study  includes  trichloroacetic  acid  (0.1%)  and 
activated  charcoal  (1-2%)  treatment  followed  by 
centrifugation. Charcoal treatment yielded a high purity HA 
and efficiently removed impurities like proteins and nucleic 
acids.  Clarified  HA  solution  thus  obtained  was  fivefold 
diluted  and  passed  through  filtration  (0.45  μm)  and 
ultrafiltration in diafiltration mode. The retentate containing 
HA was concentrated to half of the original volume with the 
recovery of 72.2% and purity of 99.2% (free of DNA and 
protein).  The  isopropyl  alcohol  precipitation  step  in  the 
presence of 0.5 M sodium chloride, has efficiently removed 
the endotoxins from the final step of the purification (data not 
shown), which is very important step and reduced the cost 
very expensive materials specifically used for the endotoxin 
removal.  Using  this  process,  we  achieved  99.2%  purity  of 
HA  with  better  purity  compared  to  the  previous  studies 
(Brown et al., 1994; Rangaswamy & Jain, 2008).  
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The quality of HA obtained in this process complies with 
the  specifications  of  British  Pharmacopoeia  (2003)  for 
medical use with a yield of 2.3 g/L during the process (Table 
1).  Accordingly,  HA  obtained  by  a  simple,  economical 
purification method of the present invention has a high purity 
HA  (free  of  DNA  and  is  of  medical  grade.  The  molecular 
weight of HA isolated from fed batch cultures was found to 
be 2.5 ×10
6 Da. 
 
Table  1.  Purification  of  hyaluronic  acid  produced  by  S. 
zooepidemicus 3523-7. 
 
  Before 
purification 
After 
purification 
 
HA (g/L) 
 
2.320 ± 0.091 
 
1.675 ± 0.075 
 
OD260 
 
3.800 ± 0.060 
 
0.032 ± 0.008 
 
Protein (mg/L) 
 
356.00 ± 1.701 
 
1.181 ± 0.142 
HA  from  clarified  broth  was  precipitated  with  isopropyl  alcohol  and 
suspended in sodium chloride. Then HA
 solution was treated with charcoal 
for 1 h. After centrifugation HA solution was passed through a 0.45 µm 
filter, subjected to cross flow filtration and finally concentrated up to original 
volume.  
 
FTIR characterization of hyaluronic acid produced by S. 
zooepidemicus 3523-7 
FTIR  spectroscopy  is  a  powerful  method  for  the 
identification of functional groups and organic compounds by 
evaluating the transitions between vibrational states of bonds 
contained within the molecule. The FTIR spectrum of both 
test HA sample and reference standard and their waves are 
similar as shown in Figure 2 and Table 2. 
The position of the peaks in terms of wave number (cm
-1) 
of  both  the  reference  standard  and  HA  produced  by  S. 
zooepidemicus  under  optimal  conditions  are  identical  and 
correlated. This  FTIR  spectrum  of  both  reference  standard 
and  purified  HA  in  this  study  complied  with  similarity  in 
their  characterization  (Figure  2).  Standard  HA  showed 
several sharp peaks (cm
-1) such as at 611.32, at 1043.3 that 
could be due to the C-O-C stretching (Alkrad et al., 2002), at 
1411.64 that corresponds to the presence of C-O group with 
C=O combination, at 1616.06
 that indicates the presence of 
amid II group, at 2892.7 due to the C-H stretching and at 
3407.6 that confirms the presence of OH stretching. Similar 
peaks (cm
-1) are seen with the test HA as indicated in Table 
2. These six different peaks obtained in the HA sample share 
a  relatively  similar  position  when  compared  to  that  of  the 
standard. These results revealed the similarity of standard HA 
and test sample HA and the peak positions. 
 
 
Figure 2. FTIR characterization of hyaluronic acid produced 
by S. zooepidemicus strain 3523-7.  
 
Table 2. The peak number and position of the peaks (in terms 
of wave number, cm
-1) of both the reference HA standard and 
test  HA  produced  by  S  .zooepidemicus  3523-7  using  FTIR 
spectroscopy. 
 
Peak 
No 
Wave length (cm
-1) 
Reference HA standard 
Wave length (cm
-1) 
Test HA sample 
 
1 
 
611.32 
 
613.25 
 
2 
 
1043.30 
 
1041.37 
 
3 
 
1411.64 
 
1413.57 
 
4 
 
1616.06 
 
1619.91 
 
5 
 
2892.70 
 
2896.51 
 
6 
 
3407.60 
 
3424.96 
 
NMR spectral analysis of hyaluronic acid produced by S. 
zooepidemius 3523-7 
13C NMR spectroscopy is used to identify the resonances 
associated with the solvent used for the NMR sample. Peaks 
in the 
13C NMR spectra (Figure. 3) corresponding to the 86 
deuterated solvent molecules show an unique spin coupling 
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number of bonds separating the atoms and the geometry of 
the bonds relative to each other. In present study, the NMR 
spectroscopic results of HA produced in fed batch cultures of 
S. zooepidemicus exhibited similarity in chemical shift of 
13C 
as  that  of  the  reference  standard  at  the  same  operational 
conditions. The chemical shift of 
13C at 25 ppm, 57 ppm, 63.2 
ppm,  71.2  ppm,  76.1  ppm,  78.9  ppm,  82.6  ppm,  85  ppm, 
103.2 ppm, 105.9 ppm and 176.6 ppm are similar in both test 
HA sample and reference standard as shown in Figure 3. In 
the  present  study  the  exhibited  chemical  shifts  of 
13C  was 
correlated with the earlier reports (Alkrad et al., 2002; Bjarne 
et al., 1992; Scott et al., 1984; Cowman et al., 1984). 
 
 
Figure 3. NMR spectral analysis of hyaluronic acid produced by S. zooepidemius strain 3523-7 Sample.1: Reference Standard 
from Sigma Aldrich and Sample.2: In-house test sample.  
 
Conclusion 
S. zooepidemicus has produced 2.3 g/L of high molecular 
weight  HA  (2.5x10
6  Da)  under  optimal  conditions  in  fed-
batch  fermentation.  The  purification  method  developed  in 
present  study  efficiently  removed  exothermic  material, 
proteins, nucleic acids and other impurities compared to the 
conventional method and hence high recovery (72.2%) of HA 
was  obtained.  The  recovery  process  used  in  this  report  is 
simple and economical by use of trichloroacetic acid (0.1%), 
charcoal treatment, filtration and diafiltration. HA purified by 
this purification procedure yielded a high purity (99.2%) HA 
and this method could be useful for industrial purification of 
clinical  grade  HA.  Further  analysis  by  FTIR  and  NMR 
spectroscopy have revealed that HA produced in this study 
exhibited chemical properties similar to that of the reference 
standard  HA.  Hence,  this  HA  could  be  used  for  medical 
applications.   
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